tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Financial Statements

Compare
92 Followers

Mangoceuticals, Inc. Financial Overview

Mangoceuticals, Inc.'s market cap is currently $7.43M. The company's EPS TTM is $-5.72; its P/E ratio is ―; Mangoceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 731.49K$ 8.94K$ 0.00
Gross Profit$ 431.50K$ 4.85K$ 0.00
Operating Income$ -9.22M$ -1.99M$ -17.52K
EBITDA$ -9.19M$ -1.99M$ 52.56K
Net Income$ -9.21M$ -2.00M$ -17.70K
Balance Sheet
Cash & Short-Term Investments$ 739.01K$ 682.86K$ 22.55K
Total Assets$ 1.05M$ 1.00M$ 22.55K
Total Debt$ 128.68K$ 352.87K$ 39.27K
Net Debt$ -610.33K$ -330.00K$ 16.72K
Total Liabilities$ 276.04K$ 389.26K$ 39.27K
Stockholders' Equity$ 774.75K$ 614.03K$ -16.72K
Cash Flow
Free Cash Flow$ -7.00M$ -1.39M$ -17.52K
Operating Cash Flow$ -7.00M$ -1.35M$ -17.52K
Investing Cash Flow$ -3.52K$ -43.10K$ 0.00
Financing Cash Flow$ 7.06M$ 2.05M$ 40.07K
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History

Mangoceuticals, Inc. Debt to Assets

Mangoceuticals, Inc. Cash Flow

Mangoceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis